检索结果 - Wan‐Long Chuang
- Showing 1 - 20 results of 60
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
A Sustained Virological Response to Interferon or Interferon/Ribavirin Reduces Hepatocellular Carcinoma and Improves Survival in Chronic Hepatitis C: A Nationwide, Multicentre Stud... 由 Ming‐Lung Yu, Shi‐Ming Lin, Wan‐Long Chuang, Chia‐Yen Dai, Jing‐Houng Wang, Sheng‐Nan Lu, I‐Shyan Sheen, Wen‐Yu Chang, Chuan–Mo Lee, Yun–Fan Liaw
出版 2006Artigo -
11
Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1386‐patient study from Taiwan 由 Jee‐Fu Huang, Ming‐Lung Yu, C. Lee, Chia‐Yen Dai, Nan Hou, M.-Y. Hsieh, John Wang, Sheng‐Nan Lu, I‐Shyan Sheen, Shi‐Ming Lin, Wan‐Long Chuang, Yun‐Fan Liaw
出版 2007Artigo -
12
-
13
Influence of Nonalcoholic Fatty Liver Disease With Increased Liver Enzyme Levels on the Risk of Cirrhosis and Hepatocellular Carcinoma 由 Yu‐Han Huang, Chi Kuen Chan, Hye Won Lee, Claire Huang, Yen‐Ju Chen, Po-Chun Liu, Sheng‐Nan Lu, Wan‐Long Chuang, Jee‐Fu Huang, Ming‐Lung Yu, Jill Koshiol, Mei‐Hsuan Lee
出版 2022Artigo -
14
A randomised study of peginterferon and ribavirin for 16 versus 24 weeks in patients with genotype 2 chronic hepatitis C 由 Ming‐Lung Yu, CY Dai, Jee‐Fu Huang, Nan Hou, L.-P. Lee, Meng‐Hsuan Hsieh, C.-F. Chiu, Lin Zhong, Szu‐Chia Chen, Meng‐Hsuan Hsieh, Liping Wang, Wen‐Yu Chang, Wan‐Long Chuang
出版 2006Artigo -
15
Tumor Necrosis Factor-α 308.2 Polymorphism Is Associated with Advanced Hepatic Fibrosis and Higher Risk for Hepatocellular Carcinoma 由 Jen-Sing Jeng, Jung‐Fa Tsai, Lee-Yea Chuang, Mei‐Shang Ho, Zu‐Yau Lin, Min‐Yuh Hsieh, Shin-Chern Chen, Wan‐Long Chuang, Liang‐Yen Wang, Ming‐Lung Yu, Chia‐Yen Dai, Jan‐Gowth Chang
出版 2007Artigo -
16
Time-Degenerative Factors and the Risk of Hepatocellular Carcinoma after Antiviral Therapy among Hepatitis C Virus Patients: A Model for Prioritization of Treatment 由 Ming‐Lung Yu, Chung‐Feng Huang, Ming‐Lun Yeh, Pei‐Chien Tsai, Ching‐I Huang, Meng‐Hsuan Hsieh, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Jee‐Fu Huang, Chia‐Yen Dai, Wan‐Long Chuang
出版 2016Artigo -
17
Risk stratification of non-alcoholic fatty liver disease across body mass index in a community basis 由 Jee‐Fu Huang, Pei‐Chien Tsai, Ming‐Lun Yeh, Chung‐Feng Huang, Ching‐I Huang, Meng‐Hsuan Hsieh, Chia‐Yen Dai, Jeng‐Fu Yang, Shinn‐Chern Chen, Ming‐Lung Yu, Wan‐Long Chuang, Wen‐Yu Chang
出版 2019Artigo -
18
Efficacy and Safety of Pegylated Interferon Combined with Ribavirin for the Treatment of Older Patients with Chronic Hepatitis C 由 Chung‐Feng Huang, Jeng‐Fu Yang, Chia‐Yen Dai, Jee‐Fu Huang, Nai‐Jen Hou, Ming‐Yen Hsieh, Zu‐Yau Lin, Shinn‐Cherng Chen, Ming‐Yuh Hsieh, Liang‐Yen Wang, Wen‐Yu Chang, Wan‐Long Chuang, Ming‐Lung Yu
出版 2010Artigo -
19
Hepatitis C Virus Infection among Injection Drug Users with and without Human Immunodeficiency Virus Co-Infection 由 Meng‐Hsuan Hsieh, Jih‐Jin Tsai, Ming‐Yen Hsieh, Chung‐Feng Huang, Ming‐Lun Yeh, Jeng‐Fu Yang, Ko Chang, Wei‐Ru Lin, Chun‐Yu Lin, Tun‐Chieh Chen, Jee‐Fu Huang, Chia‐Yen Dai, Ming‐Lung Yu, Wan‐Long Chuang
出版 2014Artigo -
20
Shorter durations and lower doses of peginterferon alfa-2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C 由 Yun–Fan Liaw, Jidong Jia, Henry Lik‐Yuen Chan, Kyunghwa Han, Tawesak Tanwandee, Wan‐Long Chuang, Dianhui Tan, X. Y. Chen, Edward Gane, Teerha Piratvisuth, L. Chen, Qing Xie, Joseph J.�Y. Sung, Cynthia Wat, Coen Bernaards, Y. Cui, Patrick Marcellin
出版 2011Artigo
相关主题
Medicine
Internal medicine
Virus
Gastroenterology
Immunology
Hepatitis C virus
Hepatitis C
Virology
Hepatitis B virus
Hepatocellular carcinoma
Ribavirin
HBsAg
Hepatitis B
Confidence interval
Biology
Cirrhosis
Gene
Disease
Genetics
Genotype
Physics
Chronic hepatitis
Incidence (geometry)
Optics
Pegylated interferon
Hepatology
Cohort
Environmental health
Fatty liver
Intensive care medicine